Indo-Bangla Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
For the six months, sales was BDT 143.35 million compared to BDT 221.94 million a year ago. Net loss was BDT 5.57 million compared to net income of BDT 10.86 million a year ago. Basic loss per share from continuing operations was BDT 0.05 compared to basic earnings per share from continuing operations of BDT 0.09 a year ago.